Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and Challenges

Increasing incidences of multidrug resistance in pathogenic bacteria threaten our ability to treat and manage bacterial infection. The development and FDA approval of novel antibiotics have slowed over the past decade; therefore, the adoption and improvement of alternative therapeutic strategies are...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Chih-Yuan, Uzoma, Ijeoma, Moore, Richard T., Gilbert, Merle, Duplantier, Allen J., Panchal, Rekha G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2018
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790911/
https://www.ncbi.nlm.nih.gov/pubmed/29382729
http://dx.doi.org/10.1128/mBio.01932-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790911/
https://www.ncbi.nlm.nih.gov/pubmed/29382729
http://dx.doi.org/10.1128/mBio.01932-17

Ejemplares similares